According to the Swedish Venture Capital Association (SVCA), SEK 46bn has been invested in 2006, which is an increase of 14% since 2005. Venture investments (including seed, start-up, expansion) received SEK 6bn, split between 668 deals, which represents an increase of 45%. Buyouts and replacement capital received SEK 40bn, which is an increase of 10% since 2005.
Biotech company initially raised €12m in December 2018
Amount includes the capital raised by Eurazeo Growth III, which has now collected more than €500m
Allan Marchington, who will become head of ICG life sciences, says the team has a strong pipeline
Petra Bukovec is a member of Pantheon's secondaries team and is based in London